Journey Medical DERM Income Statement (2020-2026)

NASDAQ DERM
$7.66 -0.31 (-3.89%)
As of: Sep 9, 2026 · 11:58 AM EDT
Reported Financials

Journey Medical Quarterly Income Statement

Periods 24 quarters
Latest Jun 2026

Journey Medical reported revenue of $18.51M and net income of -$0.31M for the quarter ended Jun 2026, up 23.3% year over year. This income statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
19.61M17.52M23.30M18.29M16.12M15.97M12.21M17.17M34.54M15.26M13.03M14.86M14.63M13.62M13.14M15.01M17.63M16.08M15.96M18.51M
Cost of RevenueCost of Rev
11.17M9.53M8.20M7.63M7.22M7.72M6.45M7.77M6.43M2.25M6.00M5.73M4.47M4.68M4.79M4.94M5.75M5.44M6.22M6.14M
Gross Profit
8.44M7.99M15.09M10.66M8.89M8.25M5.76M9.40M28.11M13.01M7.03M9.13M10.16M8.94M8.35M10.07M11.88M10.64M9.74M12.37M
Operating items
Amortization - Intangibles
0.81M0.81M0.81M0.98M1.06M1.06M1.06M1.06M1.13M0.97M
Research & DevelopmentR&D
0.72M1.99M1.27M2.61M2.81M4.26M2.03M1.77M2.23M1.50M7.88M0.91M0.84M0.22M0.04M0.29M0.15M0.05M
Selling, General & AdministrativeSG&A
10.76M15.06M14.71M15.19M15.57M13.99M13.29M12.14M8.64M9.84M8.42M10.33M11.40M10.06M10.57M11.88M12.05M9.86M10.11M10.89M
Other Operating ExpensesOther Opex
20.78M9.53M8.20M7.63M7.22M7.72M6.45M10.91M6.43M6.01M6.82M6.54M5.29M1.11M5.86M6.00M6.82M6.50M7.34M7.11M
Operating ExpensesOpex
32.26M26.57M24.18M25.43M25.61M25.96M21.77M24.82M17.29M17.36M23.12M17.78M17.52M11.39M16.46M17.89M19.16M16.52M17.45M18.05M
Operating IncomeOp. Inc
-12.65M-9.06M-0.89M-7.14M-9.49M-9.99M-9.56M-7.65M17.25M-2.10M-10.09M-2.93M-2.89M2.23M-3.32M-2.88M-1.53M-0.44M-1.49M0.46M
EBIT
-12.65M-9.06M-0.89M-7.14M-9.49M-9.99M-9.56M-7.65M17.25M-2.10M-10.09M-2.93M-2.89M2.23M-3.32M-2.88M-1.53M-0.44M-1.49M0.46M
Non-operating items
Non Operating Interest Expenses
1.37M4.10M0.39M0.45M0.56M0.62M0.65M0.76M0.27M0.02M0.55M0.56M0.76M0.83M0.89M0.94M0.94M0.93M0.89M0.91M
Interest & Investment IncomeInt & Inv Inc
0.00M0.00M0.00M0.05M0.12M0.08M0.01M0.11M0.22M0.16M0.19M0.19M0.15M0.14M0.15M0.15M0.16M0.15M
Other Non Operating IncomeOther Non Op Inc.
-0.00M-1.29M-0.02M-0.07M-0.05M-0.03M-0.10M-0.00M-0.02M-0.03M1.12M-0.01M-0.06M-0.00M-0.02M-0.00M-0.00M
Non Operating IncomeNon Op. Inc.
-1.38M-4.36M-0.39M-0.45M-0.58M-0.63M-0.57M-0.71M-0.36M0.09M-0.35M-0.43M0.50M-0.65M-0.75M-0.86M-0.79M-0.80M-0.74M-0.75M
Net income details
EBT
-14.02M-13.42M-1.27M-7.59M-10.07M-10.63M-10.14M-8.36M16.88M-2.02M-10.44M-3.36M-2.39M1.58M-4.07M-3.74M-2.31M-1.25M-2.23M-0.30M
Tax ProvisionsTaxes
-3.38M8.34M0.10M-0.06M0.01M0.01M0.10M0.13M0.06M-2.45M0.01M
Profit After TaxPAT
-10.65M-21.75M-1.38M-7.53M-10.08M-10.64M-10.14M-8.36M16.79M-2.14M-10.44M-3.36M-2.39M1.52M-4.07M-3.80M-2.31M-1.25M-2.23M-0.31M
Income from Non-Controlling InterestsInc. Minority
0.10M0.06M
Income from Continuing OperationsIncome (Continuing)
-10.65M-21.75M-1.38M-7.53M-10.08M-10.64M-10.14M-8.36M16.79M-2.14M-10.44M-3.36M-2.39M1.58M-4.07M-3.80M-2.31M1.20M-2.23M-0.31M
Consolidated Net IncomeConsol Net Inc.
-10.65M-21.75M-1.38M-7.53M-10.08M-10.64M-10.14M-8.36M16.79M-2.14M-10.44M-3.36M-2.39M1.58M-4.07M-3.80M-2.31M1.20M-2.23M-0.31M
Income towards Parent CompanyParent Net Inc
-10.65M-21.75M-1.38M-7.53M-10.08M-10.64M-10.14M-8.36M16.79M-2.14M-10.44M-3.36M-2.39M1.58M-4.07M-3.80M-2.31M1.20M-2.23M-0.31M
Net Income towards Common StockholdersNet Income
-10.65M-21.75M-1.38M-7.53M-10.08M-10.64M-10.14M-8.36M16.79M-2.14M-10.44M-3.36M-2.39M1.58M-4.07M-3.80M-2.31M1.20M-2.23M-0.31M
Additional items
EPS (Basic)
-1.16-2.13-0.08-0.43-0.57-0.61-0.57-0.460.91-0.12-0.53-0.17-0.120.08-0.18-0.16-0.090.05-0.08-0.01
EPS (Diluted)
-1.16-2.13-0.08-0.43-0.57-0.61-0.57-0.460.80-0.12-0.53-0.17-0.120.08-0.18-0.16-0.090.05-0.08-0.01
Shares Outstanding
9.16M10.19M17.32M17.46M17.62M17.53M17.81M18.01M18.42M18.23M19.76M19.99M20.54M20.43M22.61M23.29M24.96M24.50M27.31M27.49M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
9.16M10.19M17.32M17.46M17.62M17.53M17.81M18.01M21.03M18.23M19.76M19.99M20.54M20.43M22.61M23.29M24.96M24.50M27.31M27.49M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
9.16M11.32M17.32M17.46M17.62M17.53M17.81M18.01M18.42M18.23M19.76M19.99M20.54M20.43M22.61M23.29M20.37M21.14M27.31M27.49M
EBITDA
-12.65M-9.06M-0.89M-7.14M-9.49M-9.99M-9.56M-7.65M17.25M-2.10M-10.09M-2.93M-2.89M2.23M-3.32M-2.88M-1.53M-0.44M-1.49M0.46M
Interest ExpensesInt Expense
1.37M4.10M0.39M0.45M0.56M0.62M0.65M0.76M0.27M0.02M0.55M0.56M0.76M0.83M0.89M0.94M0.94M0.93M0.89M0.91M
Tax Rate
24.07%-62.13%-8.16%0.84%-0.10%-0.12%0.56%-6.25%-1.61%196.31%-5.05%